Search clinical trials for: bimatoprost 0.03% plus timolol 0.5%
Total 965 results
-
AllerganCompletedLong-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionOcular Hypertension | GlaucomaSpain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
-
Eisai LimitedCompleted
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Open-angle GlaucomaChina
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleChina
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompleted
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
Innovative MedicalCompleted
-
Creabilis SACompletedPsoriasis VulgarisUnited States, United Kingdom
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States
-
Whitecap Biosciences, LLCCompletedOcular Hypertension | Glaucoma, Primary Open AngleUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
ForSight Vision5, Inc.CompletedOcular Hypertension | Open-Angle GlaucomaPanama
-
Haisco Pharmaceutical Group Co., Ltd.Completed
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleAustria
-
Laboratoires TheaCompletedPrimary Open Angle Glaucoma | Ocular HypertensionFrance
-
Afyon Kocatepe University HospitalCompleted
-
Laboratoires TheaCompletedOcular Hypertension GlaucomaBulgaria
-
AllerganCompletedGlaucoma, Open-AngleSpain, Portugal
-
AllerganCompletedIdiopathic Eyelash HypotrichosisRussian Federation, Sweden, United States, United Kingdom
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States, Singapore, Italy, United Kingdom, Egypt, Korea, Republic of, Argentina, Canada, Colombia, Czechia, Germany, Malaysia, New Zealand, South Africa, Turkey
-
Galderma R&DCompletedAcne VulgarisUnited States, Canada
-
MedImmune LLCAstraZenecaTerminatedLupus Erythematosus, SystemicUnited States, Mexico, Peru, South Africa, Canada
-
H. Lundbeck A/SCompleted
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleChina
-
AllerganCompletedEyelash HypotrichosisUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleChina
-
AllerganCompletedEyelash HypotrichosisKorea, Republic of
-
Indiana University School of MedicineCompleted
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States, Hong Kong, Taiwan, Spain, Israel, Australia, Austria, Belgium, Brazil, Denmark, Hungary, Peru, Philippines, Poland
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleKorea, Republic of
-
Alcon ResearchWithdrawn
-
Assiut UniversityCompletedIntraoperative ComplicationsEgypt
-
AllerganCompletedOcular Hypertension | Glaucoma, Primary Open AngleTaiwan
-
AllerganCompletedEyelash HypotrichosisJapan
-
Iperboreal Pharma SrlTerminatedEnd Stage Renal DiseaseItaly
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
Innovative MedicalCompleted
-
Rabin Medical CenterCompletedThyroid Associated OphthalmopathiesIsrael
-
University of California, San DiegoCompletedOcular Hypertension | Glaucoma | Intraocular PressureUnited States
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
AllerganCompletedEyelash HypotrichosisJapan
-
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.Recruiting
-
AllerganCompletedMeibomian Gland DysfunctionUnited States
-
Southeast Retina Center, GeorgiaGenentech, Inc.CompletedPolypoidal Choroidal VasculopathyUnited States
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleCanada